v3.26.3
REVENUES
 9 Months Ended
Sep. 30, 2026
Revenue from Contract with Customer [Abstract]  
REVENUES REVENUES
The Company’s Revenues by segment and by payer group were as follows:
Three Months Ended September 30, 2026Three Months Ended September 30, 2025
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Dx:
   Clients23 %— %— %23 %23 %— %— %23 %
   Patients10 %— %— %10 %10 %— %— %10 %
   Medicare and Medicaid8 %— %— %8 %8 %— %— %8 %
   Third party36 %— %— %36 %37 %— %— %37 %
Total Dx revenues77 %— %— %77 %78 %— %— %78 %
BLS:
Pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs9 %9 %5 %23 %9 %9 %4 %22 %
Total Revenues
86 %9 %5 %100 %87 %9 %4 %100 %
Nine Months Ended September 30, 2026Nine Months Ended September 30, 2025
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Dx:
   Clients23 %— %— %23 %24 %— %— %24 %
   Patients10 %— %— %10 %10 %— %— %10 %
   Medicare and Medicaid8 %— %— %8 %8 %— %— %8 %
   Third party37 %— %— %37 %36 %— %— %36 %
Total Dx revenues78 %— %— %78 %78 %— %— %78 %
BLS:
Pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs9 %9 %4 %22 %9 %9 %4 %22 %
Total Revenues87 %9 %4 %100 %87 %9 %4 %100 %
Revenues in the U.S. were $3,169.0 (83.2%) and $2,968.5 (83.3%) for the three months ended September 30, 2026, and 2025, respectively, and were $9,178.5 (82.8%) and $8,713.9 (83.5%) for the nine months ended September 30, 2026, and 2025, respectively.
Accounts Receivable, Unbilled Services, and Unearned Revenue
The following table provides information about accounts receivable and unbilled services from contracts with customers:
September 30, 2026December 31, 2025
Dx accounts receivable$1,624.7 $1,349.0 
BLS accounts receivable825.3 791.2 
Less: BLS allowance for credit losses(37.1)(36.4)
Accounts receivable, net$2,412.9 $2,103.8 
Gross unbilled services$148.7 $164.0 
Less: BLS allowance for credit losses(2.9)(7.1)
Unbilled services, net$145.8 $156.9 
Revenues recognized during the period that were included in the unearned revenue balance at the beginning of the period were $19.0 and $16.0 for the three months ended September 30, 2026, and 2025, respectively, and were $111.4 and $119.3 for the nine months ended September 30, 2026, and 2025, respectively.
Allowance for Credit Losses
BLS estimates future expected credit losses on Accounts receivable, net and Unbilled services, net over the remaining collection period of the underlying asset. The rollforward for the allowance for credit losses was as follows:
Accounts Receivable, netUnbilled Services, netTotal
Balance at December 31, 2025$36.4 $7.1 $43.5 
Credit loss expense8.6 — 8.6 
Write-offs(7.6)(4.2)(11.8)
Foreign currency impact
(0.3)— (0.3)
Balance at September 30, 2026$37.1 $2.9 $40.0